Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTS-HF Japan: Finerenone vs Eplerenone in Worsening Heart Failure
NCT01955694Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of finerenone in heart failure (HF), sponsored by Bayer. Started Nov 2013; status: completed.
02
Drugs
finerenone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01955694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01955694.